Acute Blood Purification

Acute Blood Purification

von: H. Suzuki, H. Hirasawa

Karger, 2010

ISBN: 9783805594790 , 204 Seiten

Format: PDF, ePUB, OL

Kopierschutz: DRM

Windows PC,Mac OSX geeignet für alle DRM-fähigen eReader Apple iPad, Android Tablet PC's Apple iPod touch, iPhone und Android Smartphones Online-Lesen für: Windows PC,Mac OSX,Linux

Preis: 133,28 EUR

Mehr zum Inhalt

Acute Blood Purification


 

Cover

1

Contents

6

Preface

9

Introduction

10

References

12

Current Status

13

Current Status of Blood Purification in Critical Care in Japan

13

Abstract

13

Methods

14

Results

15

Discussion

16

Acknowledgement

18

References

18

Terminology and Indication

20

Terminology and Classification of Blood Purification in Critical Care in Japan

20

Abstract

20

Expressions of Blood Purification in Critical Care

21

Definitions of Continuous and Intermittent Therapies

22

Classification Based on the Purification Mode Using a Hemofilter

23

Classification of Blood Purification Based on the Blood Drawing and Returning Routes

23

Selection of CHD, CHF and CHDF Based on the Elimination Efficiency

24

Expressions Used when the Volume of Blood Purification Is Increased Intentionally above the Standard Level

25

Expressions Based on the Administration Route of Substitution Fluid

26

Terms used to Express Flow Rates

26

Classification and Expressions of Hemofilters

27

Conclusion

28

References

28

Indications for Blood Purification in Critical Care

30

Abstract

30

Blood Purification in Intensive Care Units

30

Indications for Blood Purification in ICU

31

Blood Purification for Hypercytokinemia and Sepsis

33

Future Perspectives

35

References

37

Acute Renal Failure

40

Acute Kidney Injury of Non-Septic Origin Requiring Dialysis Therapy

40

Abstract

40

Pathogenesis of AKI in Cardiovascular Surgery

40

Predictive Factors for the Risk of Postoperative Dialysis

41

Intraoperative Events

42

Postoperative Events

43

Beginning Dialysis Therapy

43

Conclusion

47

References

47

Septic Acute Renal Failure

49

Abstract

49

Pathophysiology

50

Therapy

51

References

53

Non-renal Indication

56

Non-Renal Indications for Continuous Renal Replacement Therapy: Current Status in Japan

56

Abstract

56

Blood Purification Advances in Japan

57

PMMA-CHDF

59

Plasma Diafiltration

59

Online CHDF

60

Cytokine-Adsorbing Column

60

Future Perspectives

60

References

61

Continuous Hemodiafiltration Using a Polymethyl Methacrylate Membrane Hemofilter for SevereAcute Pancreatitis

63

Abstract

63

Evaluation of the Magnitude of Hypercytokinemia in Patients with SAP

64

Criteria for Initiation of and Weaning from PMMA-CHDF

65

Effects of PMMA-CHDF on Blood IL-6 Level, Clinical Parameters and Outcome

68

Effects of PMMA-CHDF on Abdominal Compartment Syndrome

69

PMMA-CHDF as a Means of Cytokine Modulation

70

Conclusion

71

References

71

Blood Purification in Fulminant Hepatic Failure

73

Abstract

73

Purpose of Blood Purification

74

Hemodialysis and Hemofiltration

75

Plasmapheresis

76

Molecular Adsorbents Recirculating System

77

Bioartificial Liver Devices

77

Clinical Implementation of Blood Purification in Our Group

77

Conclusions

80

References

80

Treatment of Severe Sepsis and Septic Shock by CHDF Using a PMMA Membrane Hemofilter as a Cytokine Modulator

82

Abstract

82

Procedures in PMMA-CHDF for the Treatment of Severe Sepsis/Septic Shock

83

Cytokine-Removing Effects of PMMA-CHDF

84

Therapeutic Effects of Early Implementation of PMMA-CHDF in Septic Shock

84

Immunomodulatory Effects of Cytokine Removal by PMMA-CHDF on Immunocompetent Cells

87

Enhancement of the Cytokine-Removing Capacity of PMMA-CHDF to Cope with Refractory Septic Shock

89

Conclusion

89

References

90

Efficacy of Continuous Hemodiafiltration with a Cytokine-Adsorbing Hemofilter in the Treatment of Acute Respiratory Distress Syndrome

92

Abstract

92

Materials and Methods

93

Results

95

Discussion

98

Conclusions

100

References

100

Blood Purification for Intoxication

102

Abstract

102

Indications for Blood Purification

103

Approach to Protein-Binding Substances

105

Case Presentation

106

Conclusion

108

References

108

Current Progresses in Methodology in Blood Purification in Critical Care

109

Current Progress in Blood Purification Methods Used in Critical Care Medicine

109

Abstract

109

Application of Blood Purification in Critical Care

110

Characteristics of Blood-Purification Methods Used in Critical Care

114

References

118

Membrane Materials for Blood Purification in Critical Care

121

Abstract

121

Materials and Methods

122

Results and Discussion

124

Conclusions

127

References

127

Anticoagulation in Acute Blood Purification for Acute Renal Failure in Critical Care

128

Abstract

128

Indications for Acute Blood Purification in Critical Care Patients

129

Modalities in Acute Blood Purification for ARF and Their Anticoagulation

129

Anticoagulation in Acute Blood Purification for ARF

131

Unfractionated Heparin

131

LMW Heparin

133

Nafamostat Mesilate

133

References

134

Equipment and Monitoring in Continuous Renal Replacement Therapy

135

Abstract

135

Selection of the Console System in CRRT

135

Composition and Monitoring of the CRRT Console

136

Management of CRRT Console System

141

References

142

Cytokine Adsorbing Columns

143

Abstract

143

CytoSorb Cartridge

145

CYT-860-DHP

145

Lixelle Column

146

CTR-001 Column

147

MPCF-X

148

Discussion

148

References

149

Plasma Dia-Filtration for Severe Sepsis

151

Abstract

151

Patients and Methods

152

Results

154

Discussion

156

Acknowledgement

157

References

157

Application of Polymyxin B Convalently Immobilized Fiber in Patients with Septic Shock

159

Abstract

159

Designing PMX

160

Animal Experiments

161

Clinical Studies

161

Drawbacks of Treatment with PMX-F

164

RCT of Treatment with PMX-F in Patients with Sepsis

164

Conclusion

165

References

165

Special Considerations in Continuous Hemodiafiltration with Critically Ill Pediatric Patients

167

Abstract

167

Advantages of CHDF over Intermittent Hemodialysis

168

CHDF Conditions for Pediatric Patients

168

Efficacy and Indications for CHDF in Pediatric Patients

168

Problems of CHDF in Pediatric Patients

169

Countermeasures to Problems Associated with CHDF in Pediatric Patients

169

Conclusions

174

References

174

Controversies in Blood Purification in Critical Care

176

Selection of Modality in Continuous Renal Replacement Therapy

176

Abstract

176

Modality in Continuous Renal Replacement Therapy (CRRT)

176

Selection of Modality in CRRT: Survival in ICU Acute Renal Failure

177

Efficacy of CRRT in Other Conditions

178

Conclusions

180

References

180

Online CHDF System: Excellent Cost-Effectiveness for Continuous Renal Replacement Therapy with High Efficacy and Individualization

182

Abstract

182

Methods and Results

183

Discussion

186

Conclusion

188

References

189

New Technology

190

‘Super High-Flux’ or ’High Cut-Off’Hemofiltration and Hemodialysis

190

Abstract

190

SHF/HCO Hemofiltration

191

Ex vivo Findings with SHF/HCO Membranes

192

Pilot Clinical Study of SHF/HCO Hemofiltration

193

Effect of SHF/HCO Membrane on Cellular Function

193

Albumin Loss and Safety Issues

194

HCO Hemodialysis

195

Another Therapeutic Target: HMGB-1 and SHF/HCO Membrane

196

Conclusions

197

References

197

Author Index

199

Subject Index

200